Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 118(32)2021 08 10.
Article in English | MEDLINE | ID: mdl-34353913

ABSTRACT

The type 2 helper effector program is driven by the master transcription factor GATA3 and can be expressed by subsets of both innate lymphoid cells (ILCs) and adaptive CD4+ T helper (Th) cells. While ILC2s and Th2 cells acquire their type 2 differentiation program under very different contexts, the distinct regulatory mechanisms governing this common program are only partially understood. Here we show that the differentiation of ILC2s, and their concomitant high level of GATA3 expression, are controlled by a Gata3 enhancer, Gata3 +674/762, that plays only a minimal role in Th2 cell differentiation. Mice lacking this enhancer exhibited defects in several but not all type 2 inflammatory responses, depending on the respective degree of ILC2 and Th2 cell involvement. Our study provides molecular insights into the different gene regulatory pathways leading to the acquisition of the GATA3-driven type 2 helper effector program in innate and adaptive lymphocytes.


Subject(s)
Enhancer Elements, Genetic , GATA3 Transcription Factor/genetics , Lymphocytes/physiology , Animals , Cell Differentiation/genetics , Female , GATA3 Transcription Factor/metabolism , Homeostasis/genetics , Immunity, Innate/genetics , Inflammation/genetics , Inflammation/physiopathology , Lymphocytes/cytology , Male , Mice, Inbred C57BL , Mice, Transgenic , Strongyloidiasis/parasitology , Strongyloidiasis/physiopathology , Th2 Cells/pathology , Th2 Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...